Relationship of Warfarin and Apixaban with Vascular Function in Patients with Atrial Fibrillation

Rehan T. Junejo; Dhiraj Gupta; Richard Snowdon; Professor Gregory Lip; James P. Fisher

doi:10.1159/000535618

Abstract

1 min read

AF patients on warfarin and apixaban exhibit similar endothelium-dependent vasodilation. Increased blood pressure negatively impacts vasodilator capacity in AF patients.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2019

Apixaban enhances endogenous fibrinolysis in patients with atrial fibrillation

Nikolaos Spinthakis, Ying X. Gue, Mohamed Farag, Manivannan Srinivasan, David Wellsted, Deepa J. Arachchillage, Professor Gregory Lip, Diana A. Gorog

Article2018

Discontinuation risk comparison among ‘real-world’ newly anticoagulated atrial fibrillation patients: Apixaban, warfarin, dabigatran, or rivaroxaban

Professor Gregory Lip, Xianying Pan, Shital Kamble, Hugh Kawabata, Jack Mardekian, Cristina Masseria, Hemant Phatak

Article2017

Effectiveness and safety of apixaban versus warfarin in non-valvular atrial fibrillation patients in “real-world” clinical practice

Xiaoyan Li, Steve Deitelzweig, Allison Keshishian, Melissa Hamilton, Ruslan Horblyuk, Kiran Gupta, Xuemei Luo, Jack Mardekian, Keith Friend, Anagha Nadkarni, Xianying Pan, Professor Gregory Lip

Article2016

Abstract 13828: Real World Bleeding Risks in Non-valvular Atrial Fibrillation Patients With Heart Failure: Contemporary EHR Results Among Prescribed Apixaban, Dabigatran, Rivaroxaban and Warfarin

Iris Lin, Ruslan Horblyuk, Jack Mardekian, Sang Hee Park, Shital Kamble, Melissa Hamilton, Younos Abdulsattar, William Petkun, Joseph Menzin, Professor Gregory Lip

Article2025

Hypertension Exacerbates Endothelial Dysfunction in Patients With Atrial Fibrillation

Samuel Thomas, Fiona L. Wilkinson, Amy R. Bland, Professor Gregory Lip, James P. Fisher, Rehan T. Junejo